Ph.D. WEI-WU HE

Insider Reports History

Location
Rockville, MD
Signature
/s/ Alexander Zukiwski, attorney-in-fact for Wei-Wu He
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ph.D. WEI-WU HE:

Company Role Class Num Shares Value Price $ Report Date Ownership
CASI Pharmaceuticals, Inc. Chairman and CEO, Director, 10%+ Owner Common Stock 644,553 15 Jun 2022 Direct
CASI Pharmaceuticals, Inc. Chairman and CEO, Director, 10%+ Owner Common Stock 44,107 13 Jun 2022 Indirect

Insider Reports Filed by Ph.D. WEI-WU HE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465922072392-he-wei-wu-2022-06-13 CASI Pharmaceuticals, Inc. 13 Jun 2022 3 +$272,506 4 Chairman and CEO, Director, 10%+ Owner 17 Jun 2022, 16:14
/report/000110465921141867-he-wei-wu-2021-11-17 CASI Pharmaceuticals, Inc. 17 Nov 2021 2 +$394,000 4 Chairman and CEO, Director 19 Nov 2021, 15:10
/report/000110465921108182-he-wei-wu-2021-08-18 CASI Pharmaceuticals, Inc. 18 Aug 2021 2 +$613,800 4 Chairman and CEO, Director 20 Aug 2021, 16:27
/report/000110465921081983-he-wei-wu-2021-06-15 CASI Pharmaceuticals, Inc. 15 Jun 2021 1 $0 4 Chairman and CEO, Director, 10%+ Owner 16 Jun 2021, 16:01